Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Distinguished professor grant to researcher in epigenetics and diabetes

Researcher in a lab.
Charlotte Ling has been awarded a distinguished professor grant within medicine and health between 2021 and 2030. Photo: Kennet Ruona

Charlotte Ling, a professor of epigenetics and diabetes at Lund University, has been awarded a distinguished professor grant in medicine and health by the Swedish Research Council. 

The grant of 50 million SEK over a period of ten years will allow Charlotte Ling to develop the research environment within epigenetics and diabetes at Lund University Diabetes Centre (LUDC). 

“I am very grateful for the distinguished professor grant and would like to express my gratitude towards former and current colleagues in my research group. My colleagues at Lund University Diabetes Centre and collaborators have also contributed in a significant way,” says Charlotte Ling, professor of epigenetics and diabetes at Lund University and a research group leader at Lund University Diabetes Centre.

An important objective with the distinguished professor grant is to create conditions for the most prominent researchers to conduct long-term and innovative research with the potential to achieve scientific breakthroughs. 

Charlotte Ling’s research group will continue its studies of the epigenetic mechanisms that may cause type 2 diabetes and metabolic disease. An important long-term goal is to translate the epigenetic findings to biomarkers and new treatments.

“The grant will give our research a long-term perspective. It will also allow me to keep staff and researchers with an in-depth knowledge of epigenetics and type 2 diabetes,” says Charlotte Ling. 

Recently, the research group discovered a combination of biomarkers that can predict which patients will benefit from metformin treatment and which patients should receive an alternative drug. This work is now continuing in order to confirm the results in a larger patient group, with the intention of developing a test for clinical use.

Distinguished professor grant within medicine and health

The Swedish Research Council has approved three distinguished professor grants within medicine and health 2021. The total grant amount for 2021–2030 is 147 million SEK.

Link to a webpage with more information about the grant amount for 2021-2030 (vr.se)
 

Photograph of researcher.

Contact

Charlotte Ling, professor of epigenetics at Lund University 

charlotte [dot] ling [at] med [dot] lu [dot] se

Link to Charlotte Ling's profile in Lund University's research portal